GLP-1 medications alter appetite and relationship with food in profound ways
[1] [2] The primary mechanism of action involves: Appetite regulation : Saxenda acts on areas of the brain that control appetite, helping patients feel fuller for longer and reducing hunger between meals [1] [2] Slowing gastric emptying : The medication delays how quickly food leaves the stomach, contributing to prolonged satiety Blood glucose regulation : Although primarily used for weight management, liraglutide also influences insulin secretion and glucagon suppression Saxenda is administered as a once-daily subcutaneous injection, with the dose gradually increased over several weeks to minimise gastrointestinal side effects
For further scientific reading, check out these peer-reviewed research studies on the peptides we offer:
Which set of risks matters more is a conversation for your provider
These medications are primarily used for type 2 diabetes, but more recently, they have gained attention for their potential in helping with weight loss
Small, simple, repeatable meals can go a long way in supporting semaglutide constipation relief without harsh interventions